Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neuroleptic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT00506909
What this trial is testing

Oxytocin Add on Study for Stable Schizophrenic Patients

Who this might be right for
Schizophrenia
David Feifel 21
Not applicableStudy completedNCT01479400
What this trial is testing

Effects of Exposed to Antipsychotics Throughout Pregnancy on Infants Development: A Prospective Study

Who this might be right for
Schizophrenia
Central South University 152
Early research (Phase 1)Study completedNCT01871974
What this trial is testing

Study to Evaluate Safety and Tolerability of FK949E in Patients With Major Depressive Disorder

Who this might be right for
Major Depressive Disorder Patients
Astellas Pharma Inc 16
Large-scale testing (Phase 3)Study completedNCT01192880
What this trial is testing

Evaluate Efficacy and Safety of Bitopertin in Participants With Persistent, Predominant Negative Symptoms of Schizophrenia

Who this might be right for
Schizophrenia
Hoffmann-La Roche 625
Not applicableStudy completedNCT01026285
What this trial is testing

InORS - International Observational Registry on Schizophrenia With Injectable Risperidone and Oral Antipsychotics

Who this might be right for
Schizophrenia
Janssen-Cilag International NV 1,085
Post-approval studies (Phase 4)Study completedNCT00423878
What this trial is testing

Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder

Who this might be right for
SchizophreniaSchizoaffective Disorder
National Institute of Mental Health (NIMH) 215
Not applicableStudy completedNCT03695289
What this trial is testing

Interactive Obesity Treatment Approach (iOTA) for Obesity Prevention in Serious Mental Illness

Who this might be right for
ObesityMentally Ill Persons
Washington University School of Medicine 30
Not applicableStudy completedNCT02007928
What this trial is testing

Assessment of Adverse Events in a Naive Pediatric Population Treated With an Antipsychotic

Who this might be right for
Dissociative DisordersSchizophrenia
Centre Hospitalier Universitaire de Nice 200
Large-scale testing (Phase 3)Study completedNCT05838625
What this trial is testing

Study of Two Digital Therapeutics for the Treatment of Experiential Negative Symptoms of Schizophrenia

Who this might be right for
Schizophrenia
Click Therapeutics, Inc. 464
Testing effectiveness (Phase 2)Study completedNCT00690274
What this trial is testing

Study to Demonstrate Cognitive Enhancing Effects of BF2.649

Who this might be right for
Schizophrenia
University of Texas Southwestern Medical Center 52
Early research (Phase 1)Study completedNCT02447835
What this trial is testing

Effect of Short Term Atypical Antipsychotic Administration Compared to Placebo on Hepatic Insulin Extraction

Who this might be right for
Normal Non-fluency
Michael Rickels 15
Large-scale testing (Phase 3)Study completedNCT00198107
What this trial is testing

Evaluating the Effectiveness of Aripiprazole and D-Cycloserine to Treat Symptoms Associated With Autism

Who this might be right for
Autistic Disorder
Indiana University 81
Not applicableNot Yet RecruitingNCT07386483
What this trial is testing

Strategic Timing of Resistance Training to Guard Against Antipsychotic-Induced Metabolic Syndrome

Who this might be right for
Psychosis
University College Dublin 40
Post-approval studies (Phase 4)Study completedNCT00378183
What this trial is testing

A Study Comparing Three Strategies to Switch Patients With Schizophrenia or Schizoaffective Disorder to Risperidone After Unsuccessful Treatment With Olanzapine.

Who this might be right for
Schizoaffective DisorderSchizophrenia
Janssen, LP 120
Post-approval studies (Phase 4)UnknownNCT05146245
What this trial is testing

Safety and Pharmacokinetics of Antipsychotics in Children 2: Studying TDM in an RCT

Who this might be right for
Autism Spectrum Disorder
Erasmus Medical Center 140
Post-approval studies (Phase 4)Study completedNCT01050582
What this trial is testing

Evaluate the Safety and the Effects of Risperidone Compared With Other Atypical Antipsychotic Drugs on the Growth and Sexual Maturation in Children

Who this might be right for
SchizophreniaBipolar DisorderAutistic Disorder+1 more
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 244
Not applicableStudy completedNCT01185418
What this trial is testing

Evaluation of Negative Symptoms and Cognitive Function After Administration of Antipsychotics in Healthy Volunteer

Who this might be right for
Normal Volunteers
Chonbuk National University Hospital 80
Post-approval studies (Phase 4)Study completedNCT02640300
What this trial is testing

Switching Antipsychotics: Abrupt Discontinuation Versus Overlap

Who this might be right for
SchizophreniaSchizoaffective Disorder
Centre for Addiction and Mental Health 33
Post-approval studies (Phase 4)Ended earlyNCT01844700
What this trial is testing

1/2-MC4R Genotype and Pediatric Antipsychotic Drug- Induced Weight Gain

Who this might be right for
High Risk MC4R GenotypeLow Risk MC4R GenotypeOne Week or Less Antipsychotic Lifetime Exposure
Northwell Health 14
Post-approval studies (Phase 4)Study completedNCT00802100
What this trial is testing

Comparison of Optimal Antipsychotic Treatments for Adults With Schizophrenia

Who this might be right for
Schizophrenia
National Institute of Mental Health (NIMH) 21
Next Page